Nuvation Bio Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Nuvation Bio Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Nuvation Bio Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.47M, a 38.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.47M -$1.56M -38.7% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $2.72M -$519K -16% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $3.17M -$351K -9.97% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $3.61M -$186K -4.91% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $4.03M -$27K -0.67% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $3.24M -$1.2M -27% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $3.52M +$919K +35.3% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $3.79M +$920K +32% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $4.06M Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $4.44M Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $2.6M Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $2.87M -$1.03M -26.4% Dec 31, 2021 10-K 2023-03-15
Q4 2020 $3.9M Jan 1, 2021 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.